- Could MRI Help Speed Up CMT1A Research? New Findings from Professor Mary M. Reilly, MBE
A newly published study led by CMTA’s Strategy to Accelerate Research (CMTA-STAR) Clinical Expert Board Co-Chair Professor Mary M. Reilly, MBE, MD, and colleagues explores how MRI can track disease progression in CMT1A and serve as a potential biomarker for ...Read more ... - CMTA Announces New Center of Excellence in CanadaThe Charcot-Marie-Tooth Association (CMTA), the world’s largest philanthropic funder of Charcot-Marie-Tooth disease (CMT) research, is proud to announce the designation of Hernan Gonorazky, MD, at The Hospital for Sick Children (SickKids) in Toronto, Ontario, as a CMTA Center of Excellence. Dr. ...Read more ...
- CMTA Invests $210K in Long-Read Sequencing to Accelerate CMT Gene DiscoveryToday, the Charcot-Marie-Tooth Association (CMTA) announced a $210,000 investment to advance gene discovery and improve diagnostic success for people with Charcot-Marie-Tooth disease (CMT). Led by Andrea Cortese, MD, PhD, at University College London, this new CMTA Strategy To Accelerate Research ...Read more ...
- CMT2F Study Achieves Recruitment Goal, Expands to Include Additional ParticipantsAn international team of researchers from the Inherited Neuropathies Consortium (INC), led by CMTA’s Strategy To Accelerate Research (CMTA-STAR) Advisory Board Member Michael Shy, MD, at the University of Iowa, has successfully reached full enrollment for INC’s CMT2F Natural History ...Read more ...
- CMTA Announces Its First Center of Excellence in ScotlandThe Charcot-Marie-Tooth Association (CMTA), the world’s largest philanthropic funder of Charcot-Marie-Tooth disease (CMT) research, is proud to announce the designation of Katie Brennan, MD, PhD, at Queen Elizabeth University Hospital (QEUH) in Glasgow, Scotland, as a CMTA Center of Excellence, ...Read more ...
Your legacy can help bring an end to CMT. Learn how a planned gift can make an impact for generations to come.
